Clinical Trial: Contrast Enhanced Mammography or Breast Magnetic Resonance: Which Choice for Optimal Diagnostic Performance?

U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06843083) titled 'Contrast Enhanced Mammography or Breast Magnetic Resonance: Which Choice for Optimal Diagnostic Performance?' on Feb. 14.

Brief Summary: This study compares the diagnostic performance of Contrast-Enhanced Mammography (CEM) and Breast MRI in evaluating breast lesions. It aims to assess sensitivity, specificity, and diagnostic accuracy to identify the optimal imaging modality for clinical scenarios such as dense breast tissue and high-risk populations.

Study Start Date: Feb. 01

Study Type: OBSERVATIONAL

Condition: Breast Cancer Prevention Breast Cancer Diagnosis

Intervention: DIAGNOSTIC_TEST: CEM protocol

CEM combines low-energ...